Aviva Goel

Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

Priya Koppikar, Neha Bhagwat, Outi Kilpivaara et al. · Nature · 2012 · 367 citations · Full text

Life Sciences, Immunology, Pharmacology +9

Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer

Lucía Regales, Yixuan Gong, Ronglai Shen et al. · Journal of Clinical Investigation · 2009 · 366 citations · Full text

Medicine, Oncology, Pharmacology +17

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

Martin L. Sos, Stefanie Fischer, Roland T. Ullrich et al. · Proceedings of the National Academy of Sciences · 2009 · 256 citations · Full text

Medicine, Genetics, Oncology +17

Niche Cadherins Control the Quiescence-to-Activation Transition in Muscle Stem Cells

Aviva Goel, Marysia-Kolbe Rieder, Hans-Henning Arnold et al. · Cell Reports · 2017 · 145 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent

Rita Andraos, Zhiyan Qian, Débora Bonenfant et al. · Cancer Discovery · 2012 · 130 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17